Pharmacophore- and QSAR-guided discovery of natural product inhibitors targeting dehydrosqualene synthase in Staphylococcus aureus
Abstract
Dehydrosqualene synthase is a validated antibacterial target involved in Staphylococcus aureus staphyloxanthin biosynthesis, a key factor in oxidative stress resistance and virulence. From a dataset of 299,845 natural products, we applied pharmacophore-based screening followed by QSAR-based screening, identifying 1,978 compounds with predicted Ki values of 100 nM or lower. Among them, 47 molecules showed remarkable predicted activity, with Ki values lower than 1.0 nanomolar. Notably, despite the wide chemical diversity of the library evaluated and the fact that the models were not trained with certain scaffolds of known inhibitors of staphyloxanthin biosynthesis, nine of these chemotypes were recovered among these top candidates, demonstrating the ability of the models to capture relevant structural features beyond the training data. Five representative compounds from this group showed high binding affinity and stable interactions with key CrtM residues in molecular dynamics simulations, reflecting the potential of the overall set as a source of promising leads for novel antivirulence agents targeting dehydrosqualene synthase in S. aureus.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.